Click for best price
Idiopathic Gastroparesis Drugs Market Size, Share 2022
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
This report contains market size and forecasts of Idiopathic Gastroparesis Drugs in Global, including the following market information:
Global Idiopathic Gastroparesis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Idiopathic Gastroparesis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prokinetic Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Idiopathic Gastroparesis Drugs include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm and Ani Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Idiopathic Gastroparesis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Idiopathic Gastroparesis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Idiopathic Gastroparesis Drugs Market Segment Percentages, by Type, 2021 (%)
Prokinetic Agents
Antiemetic Agents
Others
Global Idiopathic Gastroparesis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Idiopathic Gastroparesis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
Global Idiopathic Gastroparesis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Idiopathic Gastroparesis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Idiopathic Gastroparesis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Idiopathic Gastroparesis Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
| Report Attributes |
Report Details |
| Report Title |
Idiopathic Gastroparesis Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Idiopathic Gastroparesis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Idiopathic Gastroparesis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Idiopathic Gastroparesis Drugs Overall Market Size
2.1 Global Idiopathic Gastroparesis Drugs Market Size: 2021 VS 2028
2.2 Global Idiopathic Gastroparesis Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Idiopathic Gastroparesis Drugs Players in Global Market
3.2 Top Global Idiopathic Gastroparesis Drugs Companies Ranked by Revenue
3.3 Global Idiopathic Gastroparesis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Idiopathic Gastroparesis Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Idiopathic Gastroparesis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Idiopathic Gastroparesis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Idiopathic Gastroparesis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Idiopathic Gastroparesis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Idiopathic Gastroparesis Drugs Market Size Markets, 2021 & 2028
4.1.2 Prokinetic Agents
4.1.3 Antiemetic Agents
4.1.4 Others
4.2 By Type - Global Idiopathic Gastroparesis Drugs Revenue & Forecasts
4.2.1 By Type - Global Idiopathic Gastroparesis Drugs Revenue, 2017-2022
4.2.2 By Type - Global Idiopathic Gastroparesis Drugs Revenue, 2023-2028
4.2.3 By Type - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Idiopathic Gastroparesis Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Private Clinics
5.1.4 Drug Stores
5.1.5 E-Commerce
5.2 By Application - Global Idiopathic Gastroparesis Drugs Revenue & Forecasts
5.2.1 By Application - Global Idiopathic Gastroparesis Drugs Revenue, 2017-2022
5.2.2 By Application - Global Idiopathic Gastroparesis Drugs Revenue, 2023-2028
5.2.3 By Application - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Idiopathic Gastroparesis Drugs Market Size, 2021 & 2028
6.2 By Region - Global Idiopathic Gastroparesis Drugs Revenue & Forecasts
6.2.1 By Region - Global Idiopathic Gastroparesis Drugs Revenue, 2017-2022
6.2.2 By Region - Global Idiopathic Gastroparesis Drugs Revenue, 2023-2028
6.2.3 By Region - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Idiopathic Gastroparesis Drugs Revenue, 2017-2028
6.3.2 US Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.3.3 Canada Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.3.4 Mexico Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Idiopathic Gastroparesis Drugs Revenue, 2017-2028
6.4.2 Germany Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.3 France Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.4 U.K. Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.5 Italy Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.6 Russia Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.8 Benelux Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Idiopathic Gastroparesis Drugs Revenue, 2017-2028
6.5.2 China Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.5.3 Japan Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.5.4 South Korea Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.5.6 India Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Idiopathic Gastroparesis Drugs Revenue, 2017-2028
6.6.2 Brazil Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.6.3 Argentina Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Idiopathic Gastroparesis Drugs Revenue, 2017-2028
6.7.2 Turkey Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.7.3 Israel Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.7.5 UAE Idiopathic Gastroparesis Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Sumitomo
7.1.1 Sumitomo Corporate Summary
7.1.2 Sumitomo Business Overview
7.1.3 Sumitomo Idiopathic Gastroparesis Drugs Major Product Offerings
7.1.4 Sumitomo Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.1.5 Sumitomo Key News
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Corporate Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Major Product Offerings
7.2.4 Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.2.5 Cadila Pharmaceuticals Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Idiopathic Gastroparesis Drugs Major Product Offerings
7.3.4 Sanofi Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Idiopathic Gastroparesis Drugs Major Product Offerings
7.4.4 Teva Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.4.5 Teva Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Idiopathic Gastroparesis Drugs Major Product Offerings
7.5.4 Johnson & Johnson Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Idiopathic Gastroparesis Drugs Major Product Offerings
7.6.4 Pfizer Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.6.5 Pfizer Key News
7.7 Kyowa Kirin Pharmaceuticals
7.7.1 Kyowa Kirin Pharmaceuticals Corporate Summary
7.7.2 Kyowa Kirin Pharmaceuticals Business Overview
7.7.3 Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Major Product Offerings
7.7.4 Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.7.5 Kyowa Kirin Pharmaceuticals Key News
7.8 Hanmi Pharm
7.8.1 Hanmi Pharm Corporate Summary
7.8.2 Hanmi Pharm Business Overview
7.8.3 Hanmi Pharm Idiopathic Gastroparesis Drugs Major Product Offerings
7.8.4 Hanmi Pharm Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.8.5 Hanmi Pharm Key News
7.9 Ani Pharmaceuticals
7.9.1 Ani Pharmaceuticals Corporate Summary
7.9.2 Ani Pharmaceuticals Business Overview
7.9.3 Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Major Product Offerings
7.9.4 Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.9.5 Ani Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Idiopathic Gastroparesis Drugs Market Opportunities & Trends in Global Market
Table 2. Idiopathic Gastroparesis Drugs Market Drivers in Global Market
Table 3. Idiopathic Gastroparesis Drugs Market Restraints in Global Market
Table 4. Key Players of Idiopathic Gastroparesis Drugs in Global Market
Table 5. Top Idiopathic Gastroparesis Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Idiopathic Gastroparesis Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Idiopathic Gastroparesis Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Idiopathic Gastroparesis Drugs Product Type
Table 9. List of Global Tier 1 Idiopathic Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Idiopathic Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Idiopathic Gastroparesis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Idiopathic Gastroparesis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Idiopathic Gastroparesis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Idiopathic Gastroparesis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Idiopathic Gastroparesis Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Idiopathic Gastroparesis Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Sumitomo Corporate Summary
Table 31. Sumitomo Idiopathic Gastroparesis Drugs Product Offerings
Table 32. Sumitomo Idiopathic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Cadila Pharmaceuticals Corporate Summary
Table 34. Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Product Offerings
Table 35. Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Idiopathic Gastroparesis Drugs Product Offerings
Table 38. Sanofi Idiopathic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Teva Corporate Summary
Table 40. Teva Idiopathic Gastroparesis Drugs Product Offerings
Table 41. Teva Idiopathic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Idiopathic Gastroparesis Drugs Product Offerings
Table 44. Johnson & Johnson Idiopathic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Idiopathic Gastroparesis Drugs Product Offerings
Table 47. Pfizer Idiopathic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Kyowa Kirin Pharmaceuticals Corporate Summary
Table 49. Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Product Offerings
Table 50. Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Hanmi Pharm Corporate Summary
Table 52. Hanmi Pharm Idiopathic Gastroparesis Drugs Product Offerings
Table 53. Hanmi Pharm Idiopathic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Ani Pharmaceuticals Corporate Summary
Table 55. Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Product Offerings
Table 56. Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Idiopathic Gastroparesis Drugs Segment by Type in 2021
Figure 2. Idiopathic Gastroparesis Drugs Segment by Application in 2021
Figure 3. Global Idiopathic Gastroparesis Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Idiopathic Gastroparesis Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Idiopathic Gastroparesis Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Idiopathic Gastroparesis Drugs Revenue in 2021
Figure 8. By Type - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 12. US Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 24. China Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Sumitomo Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Hanmi Pharm Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
